SI1020464T1 - Paroxetine methansulfonate - Google Patents

Paroxetine methansulfonate

Info

Publication number
SI1020464T1
SI1020464T1 SI9930009T SI9930009T SI1020464T1 SI 1020464 T1 SI1020464 T1 SI 1020464T1 SI 9930009 T SI9930009 T SI 9930009T SI 9930009 T SI9930009 T SI 9930009T SI 1020464 T1 SI1020464 T1 SI 1020464T1
Authority
SI
Slovenia
Prior art keywords
methansulfonate
paroxetine
paroxetine methansulfonate
Prior art date
Application number
SI9930009T
Other languages
English (en)
Inventor
Andrew Simon Craig
Victor W Jacewicz
David Alan Jones
Deirdre O'keeffe
Michael Urquhart
Neal Ward
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27269380&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1020464(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9814316.7A external-priority patent/GB9814316D0/en
Priority claimed from GBGB9821732.6A external-priority patent/GB9821732D0/en
Priority claimed from GBGB9902935.7A external-priority patent/GB9902935D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of SI1020464T1 publication Critical patent/SI1020464T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Addiction (AREA)
  • Psychology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SI9930009T 1998-07-02 1999-04-23 Paroxetine methansulfonate SI1020464T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9814316.7A GB9814316D0 (en) 1998-07-02 1998-07-02 Novel compounds
GBGB9821732.6A GB9821732D0 (en) 1998-10-06 1998-10-06 Novel compound
GBGB9902935.7A GB9902935D0 (en) 1999-02-10 1999-02-10 Novel compound
EP00201290A EP1020464B1 (en) 1998-07-02 1999-04-23 Paroxetine methansulfonate

Publications (1)

Publication Number Publication Date
SI1020464T1 true SI1020464T1 (en) 2001-12-31

Family

ID=27269380

Family Applications (3)

Application Number Title Priority Date Filing Date
SI9930009T SI1020464T1 (en) 1998-07-02 1999-04-23 Paroxetine methansulfonate
SI9930482T SI1089996T1 (en) 1998-07-02 1999-04-23 Paroxetine methanesulfonate acetonitrile solvate 1:1
SI9930002T SI0970955T1 (en) 1998-07-02 1999-04-23 Paroxetine methanesulfonate

Family Applications After (2)

Application Number Title Priority Date Filing Date
SI9930482T SI1089996T1 (en) 1998-07-02 1999-04-23 Paroxetine methanesulfonate acetonitrile solvate 1:1
SI9930002T SI0970955T1 (en) 1998-07-02 1999-04-23 Paroxetine methanesulfonate

Country Status (34)

Country Link
US (4) US6063927A (OSRAM)
EP (5) EP1020464B1 (OSRAM)
JP (1) JP2002519422A (OSRAM)
KR (1) KR20010053336A (OSRAM)
CN (1) CN1127502C (OSRAM)
AR (2) AR011759A1 (OSRAM)
AT (4) ATE251155T1 (OSRAM)
AU (4) AU713877B3 (OSRAM)
BE (3) BE1011664A6 (OSRAM)
BR (1) BR9911682A (OSRAM)
CA (1) CA2269999A1 (OSRAM)
CH (1) CH689805A8 (OSRAM)
DE (5) DE19918588A1 (OSRAM)
DK (7) DK199900554A (OSRAM)
ES (4) ES2209428T3 (OSRAM)
FI (2) FI112077B (OSRAM)
FR (2) FR2780728B1 (OSRAM)
GB (5) GB2336364B (OSRAM)
GR (3) GR990100140A (OSRAM)
HU (1) HUP0102334A3 (OSRAM)
IE (5) IE20000633A1 (OSRAM)
IL (1) IL140628A (OSRAM)
IT (1) IT1312540B1 (OSRAM)
LU (1) LU90388B1 (OSRAM)
NL (4) NL1011875C2 (OSRAM)
NO (1) NO319030B1 (OSRAM)
NZ (1) NZ509180A (OSRAM)
PL (1) PL345214A1 (OSRAM)
PT (4) PT1020464E (OSRAM)
SE (1) SE9901462A0 (OSRAM)
SI (3) SI1020464T1 (OSRAM)
SK (1) SK20262000A3 (OSRAM)
TR (1) TR200100054T2 (OSRAM)
WO (1) WO2000001694A1 (OSRAM)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998401A (en) * 1995-02-28 1999-12-07 Eli Lilly And Company Naphthyl compounds, intermediates, compositions, and methods
ID24610A (id) * 1997-02-27 2000-07-27 Ajinomoto Kk Radas serta metode untuk mengkristalisasian
JP2002503248A (ja) * 1997-06-10 2002-01-29 シントン・ベスローテン・フェンノートシャップ ４−フェニルピペリジン化合物
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
US20040028582A1 (en) * 1999-03-10 2004-02-12 Smithkline Beecham Corporation Crystallization process for producing fine crystal products
USPP12225P2 (en) 1999-06-01 2001-11-27 Florfis Ag Geranium plant named ‘Fislamda’
ES2159260B1 (es) * 1999-06-22 2002-05-01 Smithkline Beechan Plc Nueva composicion de metanosulfonato de paroxetina
WO2000078290A2 (en) * 1999-06-22 2000-12-28 Smithkline Beecham P.L.C. Pharmaceutical composition comprising a salt of paroxetine
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
US6306435B1 (en) 2000-06-26 2001-10-23 Yung Shin Pharmaceutical Industrial Co. Ltd. Oral pharmaceutical preparation embedded in an oily matrix and methods of making the same
GB0015981D0 (en) * 2000-06-29 2000-08-23 Glaxo Group Ltd Novel process for preparing crystalline particles
JP2004507504A (ja) * 2000-08-28 2004-03-11 シントン・ベスローテン・フェンノートシャップ パロキセチン組成物およびその製造方法
DE20100529U1 (de) * 2001-01-11 2001-05-10 Synthon Bv Pharmazeutische Tablette umfassend Paroxetinmesylat
NL1017421C2 (nl) 2001-02-21 2002-01-15 Synthon Bv Werkwijze voor het vervaardigen van paroxetine.
CA2456233A1 (en) * 2001-08-02 2003-03-13 Spurcourt Limited Paroxetine isethionate salt, process of preparation and use in the treatment of depression
AU2003217676B2 (en) 2002-02-22 2009-06-11 Takeda Pharmaceutical Company Limited Active agent delivery systems and methods for protecting and administering active agents
US20050266082A1 (en) * 2004-05-26 2005-12-01 Patel Satishkumar A Preparation of stable paroxetine HC1 ER tablets using a melt granulation process
EP1778183B1 (en) * 2004-08-18 2018-06-27 Synthon B.V. Liquid paroxetine compositions
US20060039975A1 (en) * 2004-08-20 2006-02-23 Zalman Vilkov Paroxetine formulations
KR100672184B1 (ko) 2004-09-21 2007-01-19 주식회사종근당 파록세틴의 콜린산 또는 콜린산 유도체 염
CA2603832C (en) * 2005-04-07 2011-11-22 Xy, Inc. Flow path conditioner system
CA2629514A1 (en) * 2005-11-14 2007-05-24 Auspex Pharmaceuticals, Inc. Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties
WO2007063384A2 (en) * 2005-12-01 2007-06-07 Pfizer Products Inc. Pyrimidine derivatives for the treatment of abnormal cell growth
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
RU2487128C2 (ru) * 2007-03-09 2013-07-10 Новартис Аг Соли 3-(1н-индол-3-ил)-4-[2-(4-метилпиперазин-1-ил)хиназолин-4-ил]пиррол-2,5-диона
US20100249166A1 (en) 2007-09-19 2010-09-30 Xy, Inc. Differential evaporation potentiated disinfectant system
US8119688B2 (en) * 2007-09-19 2012-02-21 Xy, Llc Differential evaporation potentiated disinfectant system
FR2926552B1 (fr) * 2008-01-23 2010-03-26 Biocodex Procede de preparation de particules de stiripentol ayant une granulometrie definie
CN103961333B (zh) * 2014-05-07 2020-02-21 浙江华海药业股份有限公司 甲磺酸帕罗西汀胶囊及其制备方法
CN104523645A (zh) * 2014-11-20 2015-04-22 美吉斯制药（厦门）有限公司 甲磺酸帕罗西汀片芯及其包衣片的制备方法
US11111373B2 (en) 2018-12-05 2021-09-07 Chi Mei Corporation Polymethacrylate composition and optical device made therefrom, and display apparatus

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE99678C (OSRAM) *
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
US4585777A (en) * 1984-02-07 1986-04-29 A/S Ferrosan (-)-Trans-4-(4-fluorophenyl)-3-(4-methoxyphenoxy)methylpiperidine for potentiating 5-HT
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
GB8431478D0 (en) * 1984-12-13 1985-01-23 Beecham Group Plc Compounds
EP0190496A3 (en) * 1984-12-13 1987-05-27 Beecham Group Plc Piperidine derivatives having a gastro-intestinal activity
EP0223334B1 (en) * 1985-08-10 1991-07-10 Beecham Group Plc Process for the preparation of aryl-piperidine carbinols
GB8520154D0 (en) * 1985-08-10 1985-09-18 Beecham Group Plc Chemical process
EP0223430B1 (en) * 1985-10-21 1991-02-27 Honda Giken Kogyo Kabushiki Kaisha Method for controlling the solenoid current of a solenoid valve which controls the amount of suction of air in an internal combustion engine
ES2058061T3 (es) * 1985-10-25 1994-11-01 Beecham Group Plc Derivado de piperidina, su preparacion y su uso como medicamento.
IE66332B1 (en) * 1986-11-03 1995-12-27 Novo Nordisk As Piperidine compounds and their preparation and use
GB8626936D0 (en) * 1986-11-11 1986-12-10 Ferrosan As Treatment
JPS63141967A (ja) * 1986-11-21 1988-06-14 エイ・エッチ・ロビンス・カンパニー・インコーポレーテッド 抗アレルギー薬として有用な１−アリールオキシー４−［（４−アリール）−１−ピペラジニル］−２−ブタノール
GB8714707D0 (en) * 1987-06-23 1987-07-29 Beecham Group Plc Chemical process
DK715988D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Etherifikation og dealkylering af piperidin-derivater samt intermediater
DK716088D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Reduktion af piperidin-dion-derivater samt intermediat
EP0558679A1 (en) * 1990-11-24 1993-09-08 BEECHAM GROUP plc Use of paroxetine for the treatment of senile dementia, bulimia, migraine or anorexia
GB9209687D0 (en) * 1992-05-06 1992-06-17 Smithkline Beecham Plc Novel process
US5258517A (en) * 1992-08-06 1993-11-02 Sepracor, Inc. Method of preparing optically pure precursors of paroxetine
JP2773587B2 (ja) * 1992-11-30 1998-07-09 東レ株式会社 Ｏ，ｏ´−ジアシル酒石酸無水物の製造法
US5276042A (en) * 1993-04-16 1994-01-04 Crenshaw Roger T Treatment of premature ejaculation
US5546683A (en) * 1993-09-29 1996-08-20 Clark; George J. Bucket attachment device with remote controlled retractable pins
IT1274241B (it) * 1993-12-03 1997-07-15 Smithkline Beecham Farma Complessi agente terapeutico/matrice polimerica dotati di migliorate caratteristiche di sapore e composizioni farmaceutiche che li contengono
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation
US5668134A (en) * 1994-01-28 1997-09-16 G. D. Searle & Co. Method for preventing or reducing photosensitivity and/or phototoxicity reactions to medications
GB9402029D0 (en) * 1994-02-03 1994-03-30 Smithkline Beecham Plc Novel formulation
CA2143070C (en) * 1994-02-22 2001-12-18 Pankaj Modi Oral controlled release liquid suspension pharmaceutical formulation
EP0714663A3 (en) * 1994-11-28 1997-01-15 Lilly Co Eli Potentiation of drug responses by serotonin 1A receptor antagonists
AR001982A1 (es) * 1995-02-06 1998-01-07 Smithkline Beecham Plc Clorhidrato de paroxetina anhidratado, y procedimiento para su preparacion
GB2297550C2 (en) * 1995-02-06 1997-04-09 Smithkline Beecham Plc Paroxetine hydrochloride anhydrate substantially free of bound organic solvent
WO1996031197A1 (en) * 1995-04-03 1996-10-10 Abbott Laboratories Homogeneous mixtures of low temperature-melting drugs and additives for controlled release
AU721257B2 (en) * 1995-05-17 2000-06-29 Novo Nordisk A/S Process for preparing 4-aryl-piperidine derivatives
JP2813768B2 (ja) * 1995-05-24 1998-10-22 農林水産省家畜衛生試験場長 口蹄疫診断用ペプチドおよび当該ペプチドを含有する口蹄疫診断用抗原
GB9514842D0 (en) * 1995-07-20 1995-09-20 Smithkline Beecham Plc Novel formulation
EP0858460A1 (en) * 1995-10-31 1998-08-19 Merck & Co., Inc. Process for preparing substituted azetidinones
IT1276160B1 (it) * 1995-11-22 1997-10-27 Recordati Chem Pharm Composizioni farmaceutiche orali a pronto rilascio per sospensioni estemporanee
GB9526645D0 (en) * 1995-12-28 1996-02-28 Chiroscience Ltd Stereoselective synthesis
ES2117557B1 (es) * 1996-02-29 1999-07-01 Ferrer Int Nuevo procedimiento de obtencion de (-)-trans -n-p-fluorobenzoilmetil-4-(p-fluorofenil)-3- ((3,4-(metilendioxi)fenoxi ) metil)-piperidina.
JP3446468B2 (ja) * 1996-04-15 2003-09-16 旭硝子株式会社 ピペリジンカルビノール類の製造方法
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride
JP3882224B2 (ja) * 1996-05-31 2007-02-14 旭硝子株式会社 パロキセチンの製造方法
EP1394160A1 (en) * 1996-06-13 2004-03-03 SUMIKA FINE CHEMICALS Co., Ltd. Process for preparing crystalline paroxetin hydrochloride
HU221921B1 (hu) * 1996-07-08 2003-02-28 Richter Gedeon Vegyészeti Gyár Rt. N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására
US5672609A (en) * 1996-07-18 1997-09-30 Eli Lilly And Company Pyridine compounds, intermediates compositions and methods of use
CA2187128A1 (en) * 1996-10-04 1997-06-26 K. S. Keshava Murthy New and useful polymorph of anhydrous paroxetine hydrochloride
JP2002503248A (ja) * 1997-06-10 2002-01-29 シントン・ベスローテン・フェンノートシャップ ４−フェニルピペリジン化合物
CA2319652A1 (en) * 1998-02-06 1999-08-12 Michael Urquhart Salts of paroxetine
AP2000001907A0 (en) * 1998-03-16 2000-09-30 Smithkline Beecham Plc Crystalline form of paroxetine.
IL138920A0 (en) * 1998-04-09 2001-11-25 Smithkline Beecham Plc Paroxetine maleate
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
ES2159260B1 (es) * 1999-06-22 2002-05-01 Smithkline Beechan Plc Nueva composicion de metanosulfonato de paroxetina
DE20100529U1 (de) * 2001-01-11 2001-05-10 Synthon Bv Pharmazeutische Tablette umfassend Paroxetinmesylat

Also Published As

Publication number Publication date
WO2000001694A1 (en) 2000-01-13
US20020193406A1 (en) 2002-12-19
EP0970955A1 (en) 2000-01-12
TR200100054T2 (tr) 2001-06-21
US6063927A (en) 2000-05-16
PT102291A (pt) 2000-05-31
BR9911682A (pt) 2001-12-26
EP1089996A1 (en) 2001-04-11
IE20000633A1 (en) 2001-10-17
US20010023253A1 (en) 2001-09-20
NL1011875C2 (nl) 2000-03-24
ES2158778B1 (es) 2002-03-16
IES20000894A2 (en) 2001-05-30
NL1012272C1 (nl) 1999-07-12
PL345214A1 (en) 2001-12-03
JP2002519422A (ja) 2002-07-02
IL140628A0 (en) 2002-02-10
DK1020464T3 (da) 2001-09-24
NL1011875A1 (nl) 2000-01-07
LU90388B1 (fr) 2001-01-29
GR1003350B (el) 2000-03-29
SE9901462L (OSRAM)
FI990922A0 (fi) 1999-04-23
IE990344A1 (en) 2000-05-03
IT1312540B1 (it) 2002-04-22
CH689805A8 (fr) 2000-02-29
NL1011874C1 (nl) 1999-07-12
ATE195121T1 (de) 2000-08-15
EP1089996B1 (en) 2003-10-01
CA2269999A1 (en) 2000-01-02
EP1020464A1 (en) 2000-07-19
PT102291B (pt) 2002-07-31
BE1011664A6 (fr) 1999-11-09
NL1012271A1 (nl) 1999-07-12
PT1089996E (pt) 2004-02-27
DK199900234U4 (da) 2000-12-22
ATE202777T1 (de) 2001-07-15
NL1012271C2 (nl) 1999-09-23
SI0970955T1 (en) 2001-02-28
SE9901462A0 (sv) 2000-01-03
AT3185U3 (de) 2000-01-25
GB2377637A (en) 2003-01-22
DK1089996T3 (da) 2004-02-09
EP1020464B1 (en) 2001-07-04
GB2352395A (en) 2001-01-31
GB2336364B (en) 2000-05-10
EP1020463A1 (en) 2000-07-19
AU713131B3 (en) 1999-11-25
DK199900554A (da) 2000-01-03
HUP0102334A2 (hu) 2002-05-29
ES2157881T3 (es) 2001-09-01
GR3036208T3 (en) 2001-10-31
NO319030B1 (no) 2005-06-06
GB2336364A (en) 1999-10-20
AR018197A1 (es) 2001-10-31
IES990343A2 (en) 2000-01-02
DE69900007T2 (de) 2001-06-07
IES20000893A2 (en) 2001-05-30
DE60000003D1 (de) 2001-08-09
US20020035130A1 (en) 2002-03-21
GB2339428A (en) 2000-01-26
AU2392899A (en) 2000-01-20
KR20010053336A (ko) 2001-06-25
CN1315949A (zh) 2001-10-03
HUP0102334A3 (en) 2003-12-29
IES81166B2 (en) 2000-05-31
CN1127502C (zh) 2003-11-12
PT970955E (pt) 2000-11-30
PT1020464E (pt) 2001-10-30
FR2802098A1 (fr) 2001-06-15
GB9909505D0 (en) 1999-06-23
EP1288214A1 (en) 2003-03-05
DK0970955T3 (da) 2000-10-09
DE60000003T2 (de) 2002-03-21
IL140628A (en) 2004-06-20
GB2352395B (en) 2004-02-11
ES2158778A1 (es) 2001-09-01
NZ509180A (en) 2001-06-29
FI112077B (fi) 2003-10-31
AU732211B2 (en) 2001-04-12
DE69911774T2 (de) 2004-08-05
DK199900234U1 (da) 2000-12-22
DK200000390U1 (da) 2000-12-27
AU713877B3 (en) 1999-12-09
GB0119695D0 (en) 2001-10-03
GB0216752D0 (en) 2002-08-28
ES2149044T3 (es) 2000-10-16
BE1012420A6 (fr) 2000-10-03
NO991944D0 (no) 1999-04-23
FIU990190U0 (fi) 1999-04-23
GR3034328T3 (en) 2000-12-29
GR990100140A (el) 2000-03-31
ES2209428T3 (es) 2004-06-16
NO991944L (no) 2000-01-03
ATE251155T1 (de) 2003-10-15
EP0970955B1 (en) 2000-08-02
FR2780728B1 (fr) 2001-02-16
SK20262000A3 (sk) 2001-07-10
AR011759A1 (es) 2000-09-13
HK1037877A1 (en) 2002-02-22
AU3619199A (en) 2000-01-24
DE19918588A1 (de) 2000-01-27
AU732211C (en) 2004-05-06
SI1089996T1 (en) 2004-04-30
GB0026487D0 (en) 2000-12-13
DE29907248U1 (de) 1999-09-09
DE69900007D1 (de) 2000-09-07
GB2367003A (en) 2002-03-27
DK199900176U3 (da) 1999-08-13
CH689805A5 (fr) 1999-11-30
FR2780728A1 (fr) 2000-01-07
AT3185U2 (de) 1999-11-25
SE9901462D0 (sv) 1999-04-23
BE1012403A5 (fr) 2000-10-03
ITMI990866A1 (it) 2000-10-23
GB9920332D0 (en) 1999-11-03
DE69911774D1 (de) 2003-11-06
FI4209U1 (fi) 1999-11-10
FI990922L (fi) 2000-01-03

Similar Documents

Publication Publication Date Title
SI1020464T1 (en) Paroxetine methansulfonate
IL143091A0 (en) N-substituted 2-cyanopyrrolidines
IL138281A0 (en) Modified factor viii
GB9903584D0 (en) Modified calycins
IL137329A0 (en) Vla-4 antagonists
GB2341416B (en) Tie arrangement
PL350864A1 (en) 5-ht1f
PL353372A1 (en) Substituted heterocyclyl-2h-chromenes
IL138920A0 (en) Paroxetine maleate
IL138478A0 (en) Paroxetine compositions
GB9911456D0 (en) Oligohydroxyl substituted 3-urea-benzofurane-and-pyridofurane-derivatives
GB9803577D0 (en) Stays
PL352101A1 (en) Substituted phenylcyclohexanocarboxyamides
HUP0101215A3 (en) Chrystalline form of paroxetine
TW433433U (en) Improved lampstand
GB9904614D0 (en) Piperidines
GB2350861B (en) Stays
AU135297S (en) Top
GB9807179D0 (en) Neckwear
GB9803398D0 (en) Neckwear
TW386346U (en) Improved dovecote
GB9813279D0 (en) Modified receptor
GB9914578D0 (en) Truncated vetors
TW433411U (en) Improved cross-screws
TW386414U (en) Improved curtain-hanger